Frank Holler, MBA

Frank is the Chief Executive Officer of BC Advantage Funds, a Vancouver-based venture capital fund investing in emerging life science and technology companies. He served as Xenon’s CEO from February 1999 until June 2003. Prior to joining Xenon, Frank was President & CEO and co-founder of ID Biomedical Corporation as well as founding director of Angiotech Pharmaceuticals.

Frank presently serves on the board of directors of Protox Therapeutics Inc. (Chairman), Allon Therapeutics, Providence Healthcare and Genome B.C. He was previously a Director of the British Columbia Biotechnology Association from 1992 to 1998. Prior to working in biotechnology and healthcare, Frank was an investment banker with Merrill Lynch Canada and CIBC World Markets. He holds degrees in Economics (BA) and Business Administration (MBA) from the University of British Columbia.